1M6MYTD1A5AMAX
Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 7,51€ (+22.657,58%). La mediana es de 7,51€ (+22.657,58%).
| Comprar |
2 |
| Mantener |
3 |
| Vender |
0 |
Noticias Ir al feed de noticias
Vicarious Surgical cuts 2025 cash-burn forecast to $45 million
Vicarious Surgical has lowered its 2025 cash-burn forecast from $50 million to about $45 million, citing disciplined cost management and operational realignment. The company plans to issue a cash-burn forecast for 2026 before year-end. Board committees were restructured; Q3 figures showed significantly reduced operating expenses and a smaller net loss, while the stock is trading near its 52-week low. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | mar 2026 | |
|---|---|---|
| Ingresos | 0,00 | - |
| Beneficio bruto | −158,09k | - |
| Beneficio neto | −6,33M | 55,50% |
| EBITDA | −6,17M | 55,55% |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 211,22k€ |
Número de acciones | 6,48M |
Máximo/mínimo de 52 semanas | 6,63€ - 0,0257€ |
| Dividendos | No |
Beta | 1,92 |
Ratio P/E | −0,01 |
Ratio PEG | 0,00 |
Ratio P/B | 0,07 |
Ratio P/S | 0,00 |
Perfil de la empresa
| Nombre | Vicarious Surgical |
| CEO | Stephen From |
| Sede | Waltham,
ma Estados Unidos |
| Sitio web | |
| Sector | Salud |
| Industria | Tecnología sanitaria |
| Empleados | 48 |
Descubrir activos
Los accionistas de Vicarious Surgical también invierten en los siguientes activos
